JD Home Rapid Testing "12 Joint Tests for Respiratory Viruses and Bacteria" covering 10 cities nationwide
海角七号
发表于 2023-12-29 20:37:45
242
0
0
This year, there is a high incidence of respiratory diseases, and multiple pathogens such as influenza A, influenza B, Mycoplasma pneumoniae, and respiratory syncytial virus are simultaneously prevalent. To reduce the risk of cross infection that may arise from offline medical treatment for residents, JD Home Rapid Testing, in collaboration with upstream and downstream partners, has launched the "12 Joint Testing of Respiratory Viruses and Bacteria" service. After Beijing, Shanghai, Guangzhou, and Shenzhen, this service was officially launched on December 28th in Hangzhou, Wuhan, Chongqing, and Chengdu, and will cover Tianjin and Suzhou within this week, achieving the opening of 10 cities nationwide.
The "12 Joint Inspection of Respiratory Viruses and Bacteria" service of JD Quick Home Inspection can detect the infection status of 12 common respiratory pathogens such as COVID-19, Mycoplasma, and Influenza at one time. Within the cities where JD Home Quick Check service is available, users only need to search for "JD Home Quick Check" on the JD App to find the "12 Joint Respiratory Virus and Bacteria Testing" service area for appointment.
After receiving the testing kit, the user will complete the sampling of the oral and nasal swab according to the instructions in the manual. The sample will be sent by a dedicated rider to a nearby offline nationally certified medical testing institution for testing. Normally, the test report will be issued within 3 hours and automatically uploaded to the JD App. Users can view the test results online after receiving a text message reminder.
In addition, users can also communicate with doctors online in real-time through the "Ask Doctor" entrance on the page. Doctors at JD Health Internet Hospital are available 24/7 with an average response time of 30 seconds, providing professional guidance and advice to users at any time.
This service not only provides residents with a fast and convenient home self inspection experience, but also fully connects the process of testing, diagnosis and treatment, and medication, allowing users to not go out in offline links and respond quickly in online links, greatly facilitating users with needs.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- AstraZeneca: Leweichu has been approved in China for the prevention of respiratory syncytial virus infection in infants
- AstraZeneca and Sanofi have been approved in China for the prevention of respiratory syncytial virus infection in infants with nisetizumab
- The first preventive measure against respiratory syncytial virus in all infants, Le Weichu? Approved in China
- Modna mRNA respiratory syncytial virus vaccine approved for market in the European Union
-
9月が終わり、映画・テレビ業界が暗躍している。最近、愛奇芸の創始者でCEOのGONG宇氏は、映画・テレビ業界が長短の変化、AIの変化、中国映画・テレビドラマの海外進出の変化の3つの変化を経験していると発表した。 ...
- 寒郁轩良
- 昨天 14:17
- 支持
- 反对
- 回复
- 收藏
-
8月のトヨタ自動車(ダイハツ自動車と日野自動車を除く、レクサスを含む)の世界生産台数は前年同月比11.2%減の709571台、世界販売台数は前年同月比3.1%減の826863台だった。 日本本土市場では、トヨタ自動車の8月 ...
- SOGO
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
ネットワーク状況監視サイトDownDetectorによると、オーディオストリーミングプラットフォームSpotifyは日曜日に約3時間にわたる障害を経験した後、正常に回復し、ピーク時には米国の4万人以上のユーザーに影響を与 ...
- hecgdge4
- 昨天 09:33
- 支持
- 反对
- 回复
- 收藏
-
百済神州(688235.SH)はA株の有名な革新薬企業で、2017-2024年上半期、同社の各期の研究開発投資はA株の化学製薬会社(申万二級)の中で最も高く、研究開発費用は合計600億元を超えた。 しかし、百済神州にとって ...
- wylz8473
- 前天 18:36
- 支持
- 反对
- 回复
- 收藏